FreshPatents.com Logo


new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)


Similar
Filing Names

Incyte Corporation
Incyte Corporation A Delaware Corporation
Incyte Corporationn A Delaware Corporation

Popular
Companies


Web
Adobe patents
Amazon patents
Apple patents
Ebay patents
Facebook patents
Google patents
IBM patents
Linkedin patents
Microsoft patents
Oracle patents
Red Hat patents
Yahoo patents

Food/Health
Adidas
Nike patents
Pfizer patents
Monsanto patents
Medtronic patents
Kraft patents

Transportation
Boeing patents
Tesla Motors patents

Telecom
Qualcomm patents
Motorola patents
Nokia patents
RIMM patents

Industrial/Electronics
AMD
Applied Materials
Seagate patents
General Electric
Caterpillar patents
Samsung
Wal-mart patents

Incyte Corporation patents


      
Recent patent applications related to Incyte Corporation. Incyte Corporation is listed as an Agent/Assignee. Note: Incyte Corporation may have other listings under different names/spellings. We're not affiliated with Incyte Corporation, we're just tracking patents.

ARCHIVE: New 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Incyte Corporation-related inventors


Search recent Press Releases: Incyte Corporation-related press releases
Count Application # Date Incyte Corporation patents (updated weekly) - BOOKMARK this page
12010002252201/28/10Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
22015005726502/26/15 new patent  Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
32015002505601/22/15Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
42015001717301/15/15Antibodies to human transmembrane proteins
52015001154001/08/15Tricyclic heterocycles as bet protein inhibitors
62015000416501/01/15Secreted proteins
72014037729212/25/14Modulators of indoleamine 2,3-dioxygenase and methods of using the same
82014037840012/25/14Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
92014037121612/18/14Purinone derivatives as hm74a agonists
102014034303011/20/14Bipyrazole derivatives as jak inhibitors
112014031596210/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3- dioxygenase
122014027503009/18/14Tricyclic heterocycles as bet protein inhibitors
132014027503109/18/14Piperidin-4-yl azetidine derivatives as jak1 inhibitors
142014027512709/18/14Substituted heteroaryl fused derivatives as pi3k inhibitors
152014025694109/11/14Processes and intermediates for making a jak inhibitor
162014024913209/04/14Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders
172014024208608/28/14Polynucleotides encoding signal peptide-containing molecules
182014024330808/28/14Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
192014024336008/28/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
202014022727508/14/14Methods of treating and diagnosing pancreatitis
212014022727808/14/14Antibodies to human signal peptide-containing proteins
222014022834608/14/14Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
232014022137908/07/14N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
242014020021607/17/14Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
252014020022707/17/14Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
262014018753007/03/14Aza spiro alkane derivatives as inhibitors of metalloproteases
272014017140506/19/14Fused pyrazoles as fgfr inhibitors
282014017140906/19/14Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
292014015528806/05/14Methods for diagnosing cancer
302014015537706/05/143-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
312014015540406/05/14Piperazinylpiperidine derivatives as chemokine receptor antagonists
322014013535005/15/14Sustained-release dosage forms of ruxolitinib
332014012119805/01/14Tricyclic fused thiophene derivatives as jak inhibitors
342014012122205/01/14Pyrimidinones as pi3k inhibitors
352014006644803/06/14Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
362014005690602/27/14Secreted proteins
372014005791202/27/14Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
382014004581402/13/14Pyrazine derivatives as fgfr inhibitors
392014003134401/30/14Azepine inhibitors of janus kinases
402014002366301/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
412014001837401/16/14Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
422014000516601/02/14Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
432014000521001/02/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
442013034515712/26/13Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
452013034522412/26/13Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
462013032451512/05/13Imidazotriazines and imidazopyrimidines as kinase inhibitors
472013025319009/26/13Processes for preparing jak inhibitors and related intermediate compounds
482013025319109/26/13Processes for preparing jak inhibitors and related intermediate compounds
492013025319309/26/13Processes for preparing jak inhibitors and related intermediate compounds
502013024378109/19/13Signal peptide-containing proteins
512013024492709/19/13Polynucleotides encoding signal peptide-containing molecules
522013024499909/19/13Substituted heterocyclic compounds
532013022476908/29/13Methods of using chemokine panec-1 antibodies
542013022555608/29/13Azetidine and cyclobutane derivatives as jak inhibitors
552013019025007/25/13Polynucleotides encoding human signal peptide-containing proteins
562013017759007/11/13N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
572013013768105/30/13Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
582013012324605/16/13Modulators of indoleamine 2,3-dioxygenase and methods of using the same
592013011623005/09/133-aminopyrrolidine derivatives as modulators of chemokine receptors
602013009614404/18/13Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors
612013005894203/07/13Human beta-adrenergic receptor kinase polypeptide and methods
622013005983503/07/13Heterocyclylamines as pi3k inhibitors
632013006002603/07/13Processes and intermediates for making a jak inhibitor
642013004596302/21/13Cyclohexyl azetidine derivatives as jak inhibitors
652013001803401/17/13Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
662013001806801/17/13Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
672012032978212/27/12Azepine inhibitors of janus kinases
682012030146411/29/12Janus kinase inhibitors for treatment of dry eye and other eye related diseases
692012029591211/22/12Piperazinylpiperidine derivatives as chemokine receptor antagonists
702012027080910/25/12Human transmembrane proteins
712012012285805/17/12Lactam compounds and their use as pharmaceuticals
722012004096402/16/12N-substituted piperidines and their use as pharmaceuticals
732012003517202/09/12Purinone derivatives as hm74a agonists
742012001493701/19/12Human beta-adrenergic receptor kinase polypeptide and methods
752012001592801/19/12Amido compounds and their use as pharmaceuticals
762011025121510/13/11Macrocyclic compounds and their use as kinase inhibitors
772011021296709/01/11Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
782011020775408/25/11Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
792011013678106/09/11Imidazotriazines and imidazopyrimidines as kinase inhibitors
802011008681004/14/11Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d] pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
812011008215904/07/11Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
822011005321703/03/11Polynucleotides encoding signal peptide-containing molecules
832010027933311/04/10Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid
842010025611410/07/10Amido compounds and their use as pharmaceuticals
852010024067109/23/10Substituted heterocyclic compounds
862010020303908/12/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
872010019080407/29/10Macrocyclic compounds and their use as kinase inhibitors
882010017390107/08/10Substituted heterocyclic compounds
892010013740106/03/102-methylprop anamides and their use as pharmaceuticals
902010011950305/13/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
912010009961704/22/10Secreted proteins
922009031840512/24/094-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
932009029194611/26/09Lactam compounds and their use as pharmaceuticals
942009028677411/19/09Purinone derivatives as hm74a agonists
952009028677811/19/09Macrocyclic compounds and their use as kinase inhibitors
962009027468011/05/09Human phospholipases
972009023390309/17/09Azetidine and cyclobutane derivatives as jak inhibitors
982009021576608/27/09Tetracyclic inhibitors of janus kinases
992009019788708/06/09Piperazinylpiperidine derivatives as chemokine receptor antagonists
1002009018195907/16/09Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1012009012464905/14/09Aza spiro alkane derivatives as inhibitors of metalloproteases
1022009008844604/02/09Purinone derivatives as hm74a agonists
1032009007626903/19/09Purinone derivatives as hm74a agonists
1042012026367610/18/12Compositions, methods and kits relating to her-2 cleavage
1052012005807903/08/121,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
1062012001498901/19/12Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
1072011031147912/22/11Modulators of indoleamine 2,3-dioxygenase and methods of using the same
1082011022321009/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1092011022415709/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1102011017227907/14/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
1112011016518807/07/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
1122011008683504/14/11Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
1132009029880812/03/09Inhibitors of 11-beta hydroxyl steroid dehydrogenase type i and methods of using the same
1142009019786908/06/09Azepine inhibitors of janus kinases



ARCHIVE: New 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Incyte Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Incyte Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###

     SHARE